These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 10207043)

  • 1. Modulation of inositol 1,4,5-trisphosphate binding to the recombinant ligand-binding site of the type-1 inositol 1,4, 5-trisphosphate receptor by Ca2+ and calmodulin.
    Sipma H; De Smet P; Sienaert I; Vanlingen S; Missiaen L; Parys JB; De Smedt H
    J Biol Chem; 1999 Apr; 274(17):12157-62. PubMed ID: 10207043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ca2+ and calmodulin differentially modulate myo-inositol 1,4, 5-trisphosphate (IP3)-binding to the recombinant ligand-binding domains of the various IP3 receptor isoforms.
    Vanlingen S; Sipma H; De Smet P; Callewaert G; Missiaen L; De Smedt H; Parys JB
    Biochem J; 2000 Mar; 346 Pt 2(Pt 2):275-80. PubMed ID: 10677344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of inositol 1,4,5-trisphosphate binding to the various inositol 1,4,5-trisphosphate receptor isoforms by thimerosal and cyclic ADP-ribose.
    Vanlingen S; Sipma H; De Smet P; Callewaert G; Missiaen L; De Smedt H; Parys JB
    Biochem Pharmacol; 2001 Apr; 61(7):803-9. PubMed ID: 11274965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thimerosal stimulates Ca2+ flux through inositol 1,4,5-trisphosphate receptor type 1, but not type 3, via modulation of an isoform-specific Ca2+-dependent intramolecular interaction.
    Bultynck G; Szlufcik K; Kasri NN; Assefa Z; Callewaert G; Missiaen L; Parys JB; De Smedt H
    Biochem J; 2004 Jul; 381(Pt 1):87-96. PubMed ID: 15015936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel role for calmodulin: Ca2+-independent inhibition of type-1 inositol trisphosphate receptors.
    Cardy TJ; Taylor CW
    Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):447-55. PubMed ID: 9716504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and functional evidence for multiple Ca2+-binding domains in the type 1 inositol 1,4,5-trisphosphate receptor.
    Sienaert I; Missiaen L; De Smedt H; Parys JB; Sipma H; Casteels R
    J Biol Chem; 1997 Oct; 272(41):25899-906. PubMed ID: 9325322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inositol 1,4,5-trisphosphate [correction of tris-phosphate] activation of inositol trisphosphate [correction of tris-phosphate] receptor Ca2+ channel by ligand tuning of Ca2+ inhibition.
    Mak DO; McBride S; Foskett JK
    Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15821-5. PubMed ID: 9861054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRPC channel interactions with calmodulin and IP3 receptors.
    Zhu MX; Tang J
    Novartis Found Symp; 2004; 258():44-58; discussion 58-62, 98-102, 263-6. PubMed ID: 15104175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The bell-shaped Ca2+ dependence of the inositol 1,4, 5-trisphosphate-induced Ca2+ release is modulated by Ca2+/calmodulin.
    Missiaen L; Parys JB; Weidema AF; Sipma H; Vanlingen S; De Smet P; Callewaert G; De Smedt H
    J Biol Chem; 1999 May; 274(20):13748-51. PubMed ID: 10318777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A calmodulin antagonist reveals a calmodulin-independent interdomain interaction essential for activation of inositol 1,4,5-trisphosphate receptors.
    Sun Y; Taylor CW
    Biochem J; 2008 Dec; 416(2):243-53. PubMed ID: 18637794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regulation of types-1 and -3 inositol trisphosphate receptors by cytosolic Ca2+.
    Cardy TJ; Traynor D; Taylor CW
    Biochem J; 1997 Dec; 328 ( Pt 3)(Pt 3):785-93. PubMed ID: 9396721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational analysis of the ligand binding site of the inositol 1,4,5-trisphosphate receptor.
    Yoshikawa F; Morita M; Monkawa T; Michikawa T; Furuichi T; Mikoshiba K
    J Biol Chem; 1996 Jul; 271(30):18277-84. PubMed ID: 8663526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenously bound calmodulin is essential for the function of the inositol 1,4,5-trisphosphate receptor.
    Kasri NN; Török K; Galione A; Garnham C; Callewaert G; Missiaen L; Parys JB; De Smedt H
    J Biol Chem; 2006 Mar; 281(13):8332-8. PubMed ID: 16410249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of the inositol trisphosphate receptor in isolated rat hepatocytes.
    Joseph SK; Ryan SV
    J Biol Chem; 1993 Nov; 268(31):23059-65. PubMed ID: 8226822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calmodulin inhibits inositol 1,4,5-trisphosphate-induced calcium release through the purified and reconstituted inositol 1,4,5-trisphosphate receptor type 1.
    Hirota J; Michikawa T; Natsume T; Furuichi T; Mikoshiba K
    FEBS Lett; 1999 Aug; 456(2):322-6. PubMed ID: 10456332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of calcium release by immunoaffinity-purified inositol 1,4,5-trisphosphate receptor in reconstituted lipid vesicles.
    Hirota J; Michikawa T; Miyawaki A; Furuichi T; Okura I; Mikoshiba K
    J Biol Chem; 1995 Aug; 270(32):19046-51. PubMed ID: 7642567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ca2+-independent inhibition of inositol trisphosphate receptors by calmodulin: redistribution of calmodulin as a possible means of regulating Ca2+ mobilization.
    Patel S; Morris SA; Adkins CE; O'Beirne G; Taylor CW
    Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11627-32. PubMed ID: 9326661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization and function of a calmodulin-apocalmodulin-binding domain in the N-terminal part of the type 1 inositol 1,4,5-trisphosphate receptor.
    Sienaert I; Nadif Kasri N; Vanlingen S; Parys JB; Callewaert G; Missiaen L; de Smedt H
    Biochem J; 2002 Jul; 365(Pt 1):269-77. PubMed ID: 11955285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stable expression of truncated inositol 1,4,5-trisphosphate receptor subunits in 3T3 fibroblasts. Coordinate signaling changes and differential suppression of cell growth and transformation.
    Fischer GA; Clementi E; Raichman M; Südhof T; Ullrich A; Meldolesi J
    J Biol Chem; 1994 Jul; 269(30):19216-24. PubMed ID: 8034682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenine-nucleotide binding sites on the inositol 1,4,5-trisphosphate receptor bind caffeine, but not adenophostin A or cyclic ADP-ribose.
    Maes K; Missiaen L; Parys JB; Sienaert I; Bultynck G; Zizi M; De Smet P; Casteels R; De Smedt H
    Cell Calcium; 1999 Feb; 25(2):143-52. PubMed ID: 10326681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.